Skip to main content
Top
Published in: CNS Drugs 11/2009

01-11-2009 | Current Opinion

Aggressive Behaviour in Adults with Intellectual Disability

Defining the Role of Drug Treatment

Authors: Patricia Oliver-Africano, Declan Murphy, Prof. Peter Tyrer

Published in: CNS Drugs | Issue 11/2009

Login to get access

Abstract

A complex form of aggression, commonly expanded as ‘aggressive challenging behaviour’, is reported in one in four adults with intellectual disability and is often treated with antipsychotics, mood stabilizers and antidepressants. Psychological treatments, including anger and behavioural management, person-centred planning and manipulation of the environment (nidotherapy), have also been used when available but to a lesser extent. In this article, the evidence for efficacy for each intervention is examined, with data from randomized controlled trials given primacy. Very little evidence, based on limited data, can be found for the interventions of anger and behavioural management and also for the atypical antipsychotic drug, risperidone; the data available on these interventions come primarily from studies conducted in children in whom the behaviour is part of the autistic spectrum. Antipsychotic drugs, particularly the atypical group, have been the most commonly used interventions in recent years, but a recent independent randomized trial showed no benefits for either risperidone or haloperidol compared with placebo, with some evidence of a better response to placebo than either active drug in the reduction of aggression.
In the light of this uncertainty, the clinician must return to the task of collecting a careful history and mental state examination, including awareness of the setting in which the behaviour is shown, which will help with diagnosis and appropriate intervention. The choice of intervention should not be a casual one and is not likely to be chosen well if the clinician relies only on standard guidelines.
The paucity of randomized trial evidence is preventing progress in the treatment of persistent aggressive behaviour. On present evidence, the use of drug treatment should be much more sparing and reserved for those patients who are putting themselves and others at particular risk as a consequence of their behaviour; such treatment should be regarded as temporary and as adjunctive to other forms of management. There is an urgent need for larger, randomized studies of psychological interventions, which at present appear to have a higher benefit-risk ratio than drug treatment but that also have a poor evidence base. More care should be taken to avoid the term ‘aggressive challenging behaviour’ being used as a portmanteau diagnostic pseudonym when it merely represents a diverse oppositional repertoire of many aetiologies.
Literature
1.
go back to reference Tyrer P, Tyrer S. Other treatments for persistent disturbances of behaviour. In: Tyrer P, Silk K, editors. Cambridge handbook of essential treatments in psychiatry. Cambridge: Cambridge University Press, 2008: 682–9CrossRef Tyrer P, Tyrer S. Other treatments for persistent disturbances of behaviour. In: Tyrer P, Silk K, editors. Cambridge handbook of essential treatments in psychiatry. Cambridge: Cambridge University Press, 2008: 682–9CrossRef
2.
go back to reference Strydom A, Livingston G, King M, et al. Prevalence of dementia in intellectual disability using different diagnostic criteria. Br J Psychiatry 2007; 191: 150–7PubMedCrossRef Strydom A, Livingston G, King M, et al. Prevalence of dementia in intellectual disability using different diagnostic criteria. Br J Psychiatry 2007; 191: 150–7PubMedCrossRef
3.
go back to reference Emerson E, McGill P, Mansell J. Severe learning disabilities and challenging behaviours: designing high quality services. London: Chapman and Hall, 1994 Emerson E, McGill P, Mansell J. Severe learning disabilities and challenging behaviours: designing high quality services. London: Chapman and Hall, 1994
4.
go back to reference Iwata BA, Dorsey MF, Slifer KJ, et al. Toward a functional analysis of self injury. Anal Intervent Devel Disabil 1982; 2: 1–20CrossRef Iwata BA, Dorsey MF, Slifer KJ, et al. Toward a functional analysis of self injury. Anal Intervent Devel Disabil 1982; 2: 1–20CrossRef
5.
go back to reference O’Neill RE, Horner RH, Albin RW, et al. Functional analysis of problem behavior: a practical assessment guide. 2nd ed. Pacific Grove (CA): Brooks/Cole, 1997 O’Neill RE, Horner RH, Albin RW, et al. Functional analysis of problem behavior: a practical assessment guide. 2nd ed. Pacific Grove (CA): Brooks/Cole, 1997
6.
go back to reference Brylewski J, Duggan L. Antipsychotic medication for challenging behaviour in people with intellectual disability: a systematic review of randomised controlled trials. Cochrane Database Syst Rev 2007; (3): CD000377 Brylewski J, Duggan L. Antipsychotic medication for challenging behaviour in people with intellectual disability: a systematic review of randomised controlled trials. Cochrane Database Syst Rev 2007; (3): CD000377
7.
go back to reference Cooper SA, Smiley E, Morrison J, et al. Mental ill health in adults with intellectual disabilities: prevalence and associated factors. Br J Psychiatry 2007; 190: 27–35PubMedCrossRef Cooper SA, Smiley E, Morrison J, et al. Mental ill health in adults with intellectual disabilities: prevalence and associated factors. Br J Psychiatry 2007; 190: 27–35PubMedCrossRef
8.
go back to reference Jones S, Cooper SA, Smiley E, et al. Prevalence of, and factors associated with, problem behaviors in adults with intellectual disabilities. J Nerv Ment Dis 2008; 196: 678–86PubMedCrossRef Jones S, Cooper SA, Smiley E, et al. Prevalence of, and factors associated with, problem behaviors in adults with intellectual disabilities. J Nerv Ment Dis 2008; 196: 678–86PubMedCrossRef
9.
go back to reference Tenneij NH, Koot HM. Incidence, types and characteristics of aggressive behaviour in treatment facilities for adults with mild intellectual disability and severe challenging behaviour. J Intellect Disabil Res 2008; 52: 114–24PubMed Tenneij NH, Koot HM. Incidence, types and characteristics of aggressive behaviour in treatment facilities for adults with mild intellectual disability and severe challenging behaviour. J Intellect Disabil Res 2008; 52: 114–24PubMed
10.
go back to reference Smiley E, Cooper S-A, Finlayson J, et al. Incidence and predictors of mental ill-health in adults with intellectual disabilities. Br J Psychiatry 2007; 191: 313–9PubMedCrossRef Smiley E, Cooper S-A, Finlayson J, et al. Incidence and predictors of mental ill-health in adults with intellectual disabilities. Br J Psychiatry 2007; 191: 313–9PubMedCrossRef
11.
go back to reference Emerson E, Hatton C. Mental health of children and adolescents with intellectual disabilities in Britain. Br J Psychiatry 2007; 191: 493–9PubMedCrossRef Emerson E, Hatton C. Mental health of children and adolescents with intellectual disabilities in Britain. Br J Psychiatry 2007; 191: 493–9PubMedCrossRef
12.
go back to reference Emerson E, Kiernan C, Alborz A, et al. The prevalence of challenging behaviors: a total population study. Res Dev Dis 2001; 22: 77–93CrossRef Emerson E, Kiernan C, Alborz A, et al. The prevalence of challenging behaviors: a total population study. Res Dev Dis 2001; 22: 77–93CrossRef
13.
go back to reference Smith S, Branford D, Collacott DA, et al. Prevalence and cluster typology of maladaptive behaviors in a geographically defined population of adults with learning disabilities. Br J Psychiatry 1996; 169: 219–27PubMedCrossRef Smith S, Branford D, Collacott DA, et al. Prevalence and cluster typology of maladaptive behaviors in a geographically defined population of adults with learning disabilities. Br J Psychiatry 1996; 169: 219–27PubMedCrossRef
14.
go back to reference Alexander R, Cooray S. Diagnosis of personality disorders in learning disability. Br J Psychiatry 2003; 182(44 Suppl.): s28–31CrossRef Alexander R, Cooray S. Diagnosis of personality disorders in learning disability. Br J Psychiatry 2003; 182(44 Suppl.): s28–31CrossRef
15.
go back to reference Kiernan C, Reeves D, Alborz A. The use of anti-psychotic drugs with adults with learning disabilities and challenging behaviour. J Intellect Disabil Res 1995; 39: 263–74PubMedCrossRef Kiernan C, Reeves D, Alborz A. The use of anti-psychotic drugs with adults with learning disabilities and challenging behaviour. J Intellect Disabil Res 1995; 39: 263–74PubMedCrossRef
16.
go back to reference Branford D. A study of the prescribing for people with learning disabilities living in the community and in National Health Service care. J Intellect Disabil Res 1994; 38: 577–86PubMedCrossRef Branford D. A study of the prescribing for people with learning disabilities living in the community and in National Health Service care. J Intellect Disabil Res 1994; 38: 577–86PubMedCrossRef
17.
go back to reference Linaker OM. Frequency and determinants for psychotropic drug use in an institution for the mentally retarded. Br J Psychiatry 1990; 156: 525–30PubMedCrossRef Linaker OM. Frequency and determinants for psychotropic drug use in an institution for the mentally retarded. Br J Psychiatry 1990; 156: 525–30PubMedCrossRef
18.
go back to reference Thalayasingam S, Alexander RT, Singh I. The use of clozapine in adults with intellectual disability. J Intellect Disabil Res 2004; 48: 572–9PubMedCrossRef Thalayasingam S, Alexander RT, Singh I. The use of clozapine in adults with intellectual disability. J Intellect Disabil Res 2004; 48: 572–9PubMedCrossRef
19.
go back to reference Haessler F, Glaser T, Beneke LJ, et al. Zuclopenthixol in aggressive challenging behaviour in learning disability: discontinuation study. Br J Psychiatry 2007; 190: 447–8PubMedCrossRef Haessler F, Glaser T, Beneke LJ, et al. Zuclopenthixol in aggressive challenging behaviour in learning disability: discontinuation study. Br J Psychiatry 2007; 190: 447–8PubMedCrossRef
20.
go back to reference Janowsky DS, Barnhill LJ, Davis JM. Olanzapine for self-injurious, aggressive, and disruptive behaviors in intellectually disabled adults: a retrospective, open-label, naturalistic trial. J Clin Psychiatry 2003; 64: 1258–65PubMedCrossRef Janowsky DS, Barnhill LJ, Davis JM. Olanzapine for self-injurious, aggressive, and disruptive behaviors in intellectually disabled adults: a retrospective, open-label, naturalistic trial. J Clin Psychiatry 2003; 64: 1258–65PubMedCrossRef
21.
go back to reference Van den Borre R, Vermote R, Buttiens M, et al. Risperidone as add-on therapy in behavioral disturbances in mental-retardation: a double-blind placebo-controlled cross-over study. Acta Psychiat Scand 1993; 87: 167–71CrossRef Van den Borre R, Vermote R, Buttiens M, et al. Risperidone as add-on therapy in behavioral disturbances in mental-retardation: a double-blind placebo-controlled cross-over study. Acta Psychiat Scand 1993; 87: 167–71CrossRef
22.
go back to reference Hellings JA, Zarcone JR, Reese RM, et al. A crossover study of risperidone in children adolescents and adults with mental retardation. J Autism and Dev Disord 2006; 36: 401–11CrossRef Hellings JA, Zarcone JR, Reese RM, et al. A crossover study of risperidone in children adolescents and adults with mental retardation. J Autism and Dev Disord 2006; 36: 401–11CrossRef
23.
go back to reference Gagiano C, Read S, Thorpe L, et al. Short and long-term efficacy and safety of risperidone in adults with disruptive behaviour disorders. Psychopharmacol (Berl) 2005; 179: 629–36CrossRef Gagiano C, Read S, Thorpe L, et al. Short and long-term efficacy and safety of risperidone in adults with disruptive behaviour disorders. Psychopharmacol (Berl) 2005; 179: 629–36CrossRef
24.
go back to reference Tyrer P, Oliver-Africano PC, Ahmed Z, et al. Risperidone, haloperidol and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial. Lancet 2008; 371: 57–63PubMedCrossRef Tyrer P, Oliver-Africano PC, Ahmed Z, et al. Risperidone, haloperidol and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial. Lancet 2008; 371: 57–63PubMedCrossRef
25.
go back to reference McDougle CJ, Naylor ST, Cohen DJ, et al. A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry 1996; 53: 1001–8PubMedCrossRef McDougle CJ, Naylor ST, Cohen DJ, et al. A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry 1996; 53: 1001–8PubMedCrossRef
26.
go back to reference Janowsky DS, Shetty M, Barnhill LJ, et al. Serotonergic antidepressant effects on aggressive, self-injurious and destructive/disruptive behaviours in intellectually disabled adults: a retrospective, open-label, naturalistic trial. Int J Neuropsychopharmacol 2005; 8: 37–48PubMedCrossRef Janowsky DS, Shetty M, Barnhill LJ, et al. Serotonergic antidepressant effects on aggressive, self-injurious and destructive/disruptive behaviours in intellectually disabled adults: a retrospective, open-label, naturalistic trial. Int J Neuropsychopharmacol 2005; 8: 37–48PubMedCrossRef
27.
go back to reference Branford D, Bhaumik S, Nai K. Selective serotonin reuptake inhibitors for the treatment of perseverative and maladaptive behaviours of people with intellectual disability. J Intellect Disabil Res 1998; 42: 301–6PubMedCrossRef Branford D, Bhaumik S, Nai K. Selective serotonin reuptake inhibitors for the treatment of perseverative and maladaptive behaviours of people with intellectual disability. J Intellect Disabil Res 1998; 42: 301–6PubMedCrossRef
28.
go back to reference Tyrer SP, Walsh A, Edwards DE, et al. Factors associated with a good response to lithium in aggressive mentally handicapped subjects. Progr Neuropsychopharmacol Biol Psychiatry 1984; 8: 751–5CrossRef Tyrer SP, Walsh A, Edwards DE, et al. Factors associated with a good response to lithium in aggressive mentally handicapped subjects. Progr Neuropsychopharmacol Biol Psychiatry 1984; 8: 751–5CrossRef
29.
go back to reference Craft M, Ismail IA, Krisnamurti D, et al. Lithium in the treatment of aggression in mentally handicapped patients: a double-blind trial. Br J Psychiatry 1987; 150: 685–9PubMedCrossRef Craft M, Ismail IA, Krisnamurti D, et al. Lithium in the treatment of aggression in mentally handicapped patients: a double-blind trial. Br J Psychiatry 1987; 150: 685–9PubMedCrossRef
30.
go back to reference Taylor JL, Novaco RW, Gillmer B, et al. Cognitive-behavioural treatment of anger intensity among offenders with intellectual disabilities. J Appl Res Intellect Disabil 2002; 15: 151–65CrossRef Taylor JL, Novaco RW, Gillmer B, et al. Cognitive-behavioural treatment of anger intensity among offenders with intellectual disabilities. J Appl Res Intellect Disabil 2002; 15: 151–65CrossRef
31.
go back to reference Willner P, Jones J, Tams R, et al. A randomised controlled trial of the efficacy of a cognitive-behavioural anger management group for adults with learning disabilities. J Appl Res Intellect Disabil 2002; 15: 224–35CrossRef Willner P, Jones J, Tams R, et al. A randomised controlled trial of the efficacy of a cognitive-behavioural anger management group for adults with learning disabilities. J Appl Res Intellect Disabil 2002; 15: 224–35CrossRef
33.
go back to reference Petry N. Contingency management treatments: a uniquely American approach, or perhaps even better suited for European drug abuse treatment? Br J Psychiatry 2006; 189: 97–8PubMedCrossRef Petry N. Contingency management treatments: a uniquely American approach, or perhaps even better suited for European drug abuse treatment? Br J Psychiatry 2006; 189: 97–8PubMedCrossRef
34.
go back to reference LaGrow SJ, Repp AC. Stereotypic responding: a review of intervention research. Am J Mental Defic Res 1984; 88: 595–609 LaGrow SJ, Repp AC. Stereotypic responding: a review of intervention research. Am J Mental Defic Res 1984; 88: 595–609
35.
go back to reference Scotti JR, Evans IM, Meyer LH, et al. A meta-analysis of intervention research with problem behaviour: treatment validity and standards of practice. Am J Ment Retard 1991; 93: 233–56 Scotti JR, Evans IM, Meyer LH, et al. A meta-analysis of intervention research with problem behaviour: treatment validity and standards of practice. Am J Ment Retard 1991; 93: 233–56
36.
go back to reference Peck Peterson SM, Caniglia C, Royster AJ, et al. Blending functional communication training and choice making to improve task engagement and decrease problem behaviour. Educ Psychol 2005; 25: 257–74CrossRef Peck Peterson SM, Caniglia C, Royster AJ, et al. Blending functional communication training and choice making to improve task engagement and decrease problem behaviour. Educ Psychol 2005; 25: 257–74CrossRef
37.
go back to reference Shogren KA, Faggella-Luby M, Bae SJ, et al. The effect of choice-making as an intervention for problem behaviour: a meta-analysis. J Pos Behav Interventions 2004; 6: 228–37CrossRef Shogren KA, Faggella-Luby M, Bae SJ, et al. The effect of choice-making as an intervention for problem behaviour: a meta-analysis. J Pos Behav Interventions 2004; 6: 228–37CrossRef
38.
go back to reference Hassiotis A, Rowbotham D, Canagasaby A, et al. A randomized, single-blind, controlled trial of a specialist behavior therapy team for challenging behavior in adults with intellectual disabilities. Am J Psychiatry. In press Hassiotis A, Rowbotham D, Canagasaby A, et al. A randomized, single-blind, controlled trial of a specialist behavior therapy team for challenging behavior in adults with intellectual disabilities. Am J Psychiatry. In press
39.
go back to reference Haddock K, Jones RS. Practitioner consensus in the use of cognitive behaviour therapy for individuals with a learning disability. J Intellect Disabil 2006; 10: 221–30PubMedCrossRef Haddock K, Jones RS. Practitioner consensus in the use of cognitive behaviour therapy for individuals with a learning disability. J Intellect Disabil 2006; 10: 221–30PubMedCrossRef
40.
go back to reference Browder DM, Bambara LM, Belfiore PJ. Using a person-centred approach in community-based institutions for adults with developmental disabilities. J Behav Educ 1997; 7: 519–28CrossRef Browder DM, Bambara LM, Belfiore PJ. Using a person-centred approach in community-based institutions for adults with developmental disabilities. J Behav Educ 1997; 7: 519–28CrossRef
41.
go back to reference Hammel J. Technology and the environment: supportive resource or barrier for people with developmental disabilities? Nurs Clin North Am 2003; 38: 331–49PubMedCrossRef Hammel J. Technology and the environment: supportive resource or barrier for people with developmental disabilities? Nurs Clin North Am 2003; 38: 331–49PubMedCrossRef
42.
go back to reference Tyrer P, Bajaj P. Nidotherapy: making the environment do the therapeutic work. Adv Psychiatric Treat 2005; 11: 232–8CrossRef Tyrer P, Bajaj P. Nidotherapy: making the environment do the therapeutic work. Adv Psychiatric Treat 2005; 11: 232–8CrossRef
43.
go back to reference Tyrer P, Kramo K. Nidotherapy in practice. J Ment Health 2007; 16: 117–31CrossRef Tyrer P, Kramo K. Nidotherapy in practice. J Ment Health 2007; 16: 117–31CrossRef
44.
go back to reference Merrick J, Cahana C, Lotan M, et al. Snoezelen or controlled multisensory stimulation: treatment aspects from Israel. Scient World J 2004; 4: 307–14CrossRef Merrick J, Cahana C, Lotan M, et al. Snoezelen or controlled multisensory stimulation: treatment aspects from Israel. Scient World J 2004; 4: 307–14CrossRef
45.
go back to reference Chung JC, Lai CK, Chung PM, et al. Snoezelen for dementia. Cochrane Database Syst Rev 2002; (4): CD003152 Chung JC, Lai CK, Chung PM, et al. Snoezelen for dementia. Cochrane Database Syst Rev 2002; (4): CD003152
46.
go back to reference Savarithmu D, Bunnell T. The effects of music on clients with learning disabilities: a literature review. Complement Ther Nurs Midwifery 2002 Aug 8; 3: 160–5CrossRef Savarithmu D, Bunnell T. The effects of music on clients with learning disabilities: a literature review. Complement Ther Nurs Midwifery 2002 Aug 8; 3: 160–5CrossRef
47.
go back to reference Oliver PC, Piachaud J, Done J, et al. Difficulties in conducting a randomised controlled trial of health service interventions in intellectual disability: implications for evidence-based practice. J Intellect Disabil Res 2002; 46: 340–5PubMedCrossRef Oliver PC, Piachaud J, Done J, et al. Difficulties in conducting a randomised controlled trial of health service interventions in intellectual disability: implications for evidence-based practice. J Intellect Disabil Res 2002; 46: 340–5PubMedCrossRef
48.
go back to reference Willner P. The effectiveness of psychotherapeutic interventions for people with learning disabilities: a critical overview. J Intellect Disabil Res 2005; 49: 73–85PubMedCrossRef Willner P. The effectiveness of psychotherapeutic interventions for people with learning disabilities: a critical overview. J Intellect Disabil Res 2005; 49: 73–85PubMedCrossRef
49.
go back to reference Miller DD, Caroff SN, Davis SM, et al. Extrapyramidal side effects of antipsychotics in a randomized trial: findings from the CATIE Schizophrenia Trial. Br J Psychiatry 2008; 193: 279–88PubMedCrossRef Miller DD, Caroff SN, Davis SM, et al. Extrapyramidal side effects of antipsychotics in a randomized trial: findings from the CATIE Schizophrenia Trial. Br J Psychiatry 2008; 193: 279–88PubMedCrossRef
50.
go back to reference Brylewski J, Duggan L. Antipsychotic medication for challenging behaviour in people with intellectual disability: a systematic review of randomized controlled trials. J Intellect Disabil Res 1999; 43: 360–71PubMedCrossRef Brylewski J, Duggan L. Antipsychotic medication for challenging behaviour in people with intellectual disability: a systematic review of randomized controlled trials. J Intellect Disabil Res 1999; 43: 360–71PubMedCrossRef
51.
go back to reference La Malfa G, Lassi S, Bertelli M, et al. Reviewing the use of antipsychotic drugs in people with intellectual disability. Hum Psychopharmacol 2006; 21: 73–89PubMedCrossRef La Malfa G, Lassi S, Bertelli M, et al. Reviewing the use of antipsychotic drugs in people with intellectual disability. Hum Psychopharmacol 2006; 21: 73–89PubMedCrossRef
52.
go back to reference Ahmed Z, Fraser W, Kerr MP, et al. Reducing antipsychotic medication in people with a learning disability. Br J Psychiatry 2000; 176: 42–6PubMedCrossRef Ahmed Z, Fraser W, Kerr MP, et al. Reducing antipsychotic medication in people with a learning disability. Br J Psychiatry 2000; 176: 42–6PubMedCrossRef
53.
go back to reference Bekelman JE, Li Y, Gross PC. Scope and impact of financial conflict of interest in biomedical research: a systematic review. JAMA 2003; 289: 454–65PubMedCrossRef Bekelman JE, Li Y, Gross PC. Scope and impact of financial conflict of interest in biomedical research: a systematic review. JAMA 2003; 289: 454–65PubMedCrossRef
54.
go back to reference Tungaraza T, Poole R. Influence of drug company authorship and sponsorship on drug trial outcomes. Br J Psychiatry 2007; 191: 82–3PubMedCrossRef Tungaraza T, Poole R. Influence of drug company authorship and sponsorship on drug trial outcomes. Br J Psychiatry 2007; 191: 82–3PubMedCrossRef
55.
go back to reference Buitelaar JK, Van der Gaag RJ, Cohen-Kettenis P, et al. A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities. J Clin Psychiatry 2001; 62: 239–48PubMedCrossRef Buitelaar JK, Van der Gaag RJ, Cohen-Kettenis P, et al. A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities. J Clin Psychiatry 2001; 62: 239–48PubMedCrossRef
56.
go back to reference Aman MG, Singh NN, Stewart AW, et al. The Aberrant Behavior Checklist: a behavior rating scale for the assessment of treatment effects. Am J Ment Defic 1985; 89: 485–91PubMed Aman MG, Singh NN, Stewart AW, et al. The Aberrant Behavior Checklist: a behavior rating scale for the assessment of treatment effects. Am J Ment Defic 1985; 89: 485–91PubMed
57.
go back to reference Aman MG, De Smedt G, Derivan A, et al. Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviours in children with subaverage intelligence. Am J Psychiatry 2002; 159: 1337–46PubMedCrossRef Aman MG, De Smedt G, Derivan A, et al. Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviours in children with subaverage intelligence. Am J Psychiatry 2002; 159: 1337–46PubMedCrossRef
58.
go back to reference McDougle CJ, Scahill L, Aman MG, et al. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. Am J Psychiatry 2005; 162: 1142–8PubMedCrossRef McDougle CJ, Scahill L, Aman MG, et al. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. Am J Psychiatry 2005; 162: 1142–8PubMedCrossRef
59.
go back to reference McCracken JT, McGough J, Shah B, et al. Risperidone in children with autism and serious behavioural problems. New Engl J Med 2002; 347: 314–20PubMedCrossRef McCracken JT, McGough J, Shah B, et al. Risperidone in children with autism and serious behavioural problems. New Engl J Med 2002; 347: 314–20PubMedCrossRef
60.
go back to reference McDougle CJ, Stigler KA, Erickson CA, et al. A typical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders. J Clin Psychiatry 2008; 69 Suppl. 4: 15–20 McDougle CJ, Stigler KA, Erickson CA, et al. A typical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders. J Clin Psychiatry 2008; 69 Suppl. 4: 15–20
61.
go back to reference Janowsky DS, Kraus JE, Barnhill LJ, et al. Effects of topiramate on aggressive, self-injurious, and disruptive/ destructive behaviors in the intellectually disabled: an open-label retrospective study. J Clin Psychopharmacol 2003; 23: 500–4PubMedCrossRef Janowsky DS, Kraus JE, Barnhill LJ, et al. Effects of topiramate on aggressive, self-injurious, and disruptive/ destructive behaviors in the intellectually disabled: an open-label retrospective study. J Clin Psychopharmacol 2003; 23: 500–4PubMedCrossRef
62.
go back to reference Stolker JJ, Heerdink ER, Leufkens HG, et al. Determinants of multiple psychotropic use in patients with mild intellectual disabilities or borderline intellectual function and psychiatric or behavioural disorders. Gen Hosp Psychiatry 2001; 23: 345–9PubMedCrossRef Stolker JJ, Heerdink ER, Leufkens HG, et al. Determinants of multiple psychotropic use in patients with mild intellectual disabilities or borderline intellectual function and psychiatric or behavioural disorders. Gen Hosp Psychiatry 2001; 23: 345–9PubMedCrossRef
63.
go back to reference Rangecroft MEH, Tyrer SP, Berney TP. The use of seclusion and emergency medication in a hospital for people with learning disability. Br J Psychiatry 1997; 170: 273–7PubMedCrossRef Rangecroft MEH, Tyrer SP, Berney TP. The use of seclusion and emergency medication in a hospital for people with learning disability. Br J Psychiatry 1997; 170: 273–7PubMedCrossRef
64.
go back to reference Fisher WW, Adelinis JD, Volkert VM, et al. Assessing preferences for positive and negative reinforcement during treatment of destructive behaviour with functional communication training. Res Development Disabil 2005; 26: 153–68CrossRef Fisher WW, Adelinis JD, Volkert VM, et al. Assessing preferences for positive and negative reinforcement during treatment of destructive behaviour with functional communication training. Res Development Disabil 2005; 26: 153–68CrossRef
65.
go back to reference Tyrer P, Sensky T, Mitchard S. The principles of nidotherapy in the treatment of persistent mental and personality disorders. Psychother Psychosom 2003; 72: 350–6PubMedCrossRef Tyrer P, Sensky T, Mitchard S. The principles of nidotherapy in the treatment of persistent mental and personality disorders. Psychother Psychosom 2003; 72: 350–6PubMedCrossRef
66.
go back to reference Stirling C, McHugh A. Developing a non-aversive intervention strategy in the management of aggression and violence for people with learning disabilities using natural therapeutic holding. J Adv Nurs 1998; 27: 503–9PubMedCrossRef Stirling C, McHugh A. Developing a non-aversive intervention strategy in the management of aggression and violence for people with learning disabilities using natural therapeutic holding. J Adv Nurs 1998; 27: 503–9PubMedCrossRef
67.
go back to reference Hassiotis A, Hall I. Behavioural and cognitive-behavioural interventions for outwardly-directed aggressive behaviour in people with learning disabilities. Cochrane Database Syst Rev 2004 Oct 18; (4): CD003406 Hassiotis A, Hall I. Behavioural and cognitive-behavioural interventions for outwardly-directed aggressive behaviour in people with learning disabilities. Cochrane Database Syst Rev 2004 Oct 18; (4): CD003406
68.
go back to reference Hassiotis AA, Hall I. Behavioural and cognitive-behavioural interventions for outwardly-directed aggressive behaviour in people with learning disabilities. Cochrane Database Syst Rev 2008 Jul 16; (3): CD0034062008 Hassiotis AA, Hall I. Behavioural and cognitive-behavioural interventions for outwardly-directed aggressive behaviour in people with learning disabilities. Cochrane Database Syst Rev 2008 Jul 16; (3): CD0034062008
69.
go back to reference Tyrer P, Oliver-Africano P, Romeo R, et al. Neuroleptics in the treatment of aggressive challenging behaviour for people with intellectual disabilities: a randomised controlled trial (NACHBID trial). Health Technol Assess 2009; 13(21): iii–iv, ix-xi, 1-54PubMed Tyrer P, Oliver-Africano P, Romeo R, et al. Neuroleptics in the treatment of aggressive challenging behaviour for people with intellectual disabilities: a randomised controlled trial (NACHBID trial). Health Technol Assess 2009; 13(21): iii–iv, ix-xi, 1-54PubMed
70.
go back to reference Morgan VA, Leonard H, Bourke J, et al. Intellectual disability co-occurring with schizophrenia and other psychiatric illness: population-based study. Br J Psychiatry 2008; 193: 364–72PubMedCrossRef Morgan VA, Leonard H, Bourke J, et al. Intellectual disability co-occurring with schizophrenia and other psychiatric illness: population-based study. Br J Psychiatry 2008; 193: 364–72PubMedCrossRef
Metadata
Title
Aggressive Behaviour in Adults with Intellectual Disability
Defining the Role of Drug Treatment
Authors
Patricia Oliver-Africano
Declan Murphy
Prof. Peter Tyrer
Publication date
01-11-2009
Publisher
Springer International Publishing
Published in
CNS Drugs / Issue 11/2009
Print ISSN: 1172-7047
Electronic ISSN: 1179-1934
DOI
https://doi.org/10.2165/11310930-000000000-00000

Other articles of this Issue 11/2009

CNS Drugs 11/2009 Go to the issue

Therapy in Practice

Adjustment Disorder

Current Opinion

Of Mice and Men